Related Experiment Video
Updated: Jul 20, 2026

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
Silent Giant: A Case of Dedifferentiated Retroperitoneal Liposarcoma Presenting as an Incidental Mesenteric Mass
Danielle A Rowe1,2, William B Bowers1,2, Heather L Mateja1,2
1General Surgery, American University of Antigua, Osbourn, ATG.
Abstract:
Dedifferentiated liposarcoma (DDL) is a rare and aggressive subtype of liposarcoma, arising most commonly in the retroperitoneum but rarely presenting in the mesentery. Due to its rarity, mesenteric DDL poses significant diagnostic and therapeutic challenges, with few cases documented in the literature. Here, we report the case of a 76-year-old female admitted with acute respiratory failure secondary to pneumonia, during which an incidental finding of a large mesenteric mass was noted on computed tomography (CT) imaging. An elective exploratory laparotomy was performed one month later, revealing a large mesenteric tumor adherent to the terminal ileum, cecum, and ascending colon. En bloc resection, including right hemicolectomy and partial small bowel resection, was successfully performed. Pathology confirmed an intermediate-grade DDL. This case underscores the importance of considering mesenteric DDL in the differential diagnosis of large, asymptomatic intra-abdominal masses. Complete surgical resection remains the mainstay of treatment, with a critical focus on achieving negative margins to reduce recurrence risk. Given the aggressive nature of DDL, vigilant long-term follow-up is essential. This report contributes to the limited body of literature on mesenteric DDL and highlights the challenges in its diagnosis and management.
Related Concept Videos
Pleiotropy
Cancers Originate from Somatic Mutations in a Single Cell
The Tumor Microenvironment
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancers Originate from Somatic Mutations in a Single Cell

